Breast cancer drugs such as Herceptin as well as new uses for multi-cancer drug Avastin helped Swiss pharmaceutical firm Roche grow sales by 3 percent during the first quarter. Group sales rose 3 percent to 11.83 billion Swiss francs .

Click here to read original article